These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7261335)

  • 1. Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination.
    Jolley ME; Stroupe SD; Schwenzer KS; Wang CJ; Lu-Steffes M; Hill HD; Popelka SR; Holen JT; Kelso DM
    Clin Chem; 1981 Sep; 27(9):1575-9. PubMed ID: 7261335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of five therapeutic drugs using dry film multilayer technology on the OPUS immunoassay system.
    Jandreski MA; Shah JC; Garbincius J; Bermes EW
    J Clin Lab Anal; 1991; 5(6):415-21. PubMed ID: 1774606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer.
    Oeltgen PR; Shank WA; Blouin RA; Clark T
    Ther Drug Monit; 1984; 6(3):360-7. PubMed ID: 6390799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Abbott TDx for the stat measurement of phenobarbital, phenytoin, carbamazepine, and theophylline.
    Loomis KF; Frye RM
    Am J Clin Pathol; 1983 Nov; 80(5):686-91. PubMed ID: 6637881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma.
    Jolley ME
    J Anal Toxicol; 1981; 5(5):236-40. PubMed ID: 7321548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automation of the homogeneous substrate-labeled fluorescent immunoassay for theophylline in serum: application to the determination of phenytoin and phenobarbital in serum.
    Fingerhut B; Costanzo R; Chaudri Z; Rizvi S
    Ther Drug Monit; 1982; 4(4):419-25. PubMed ID: 6760476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hyperlipidemia on therapeutic drug assays.
    Baer DM; Paulson RA
    Ther Drug Monit; 1987; 9(1):72-7. PubMed ID: 3554630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a fluorescence polarization immunoassay system evaluated by therapeutic monitoring of four drugs.
    Zaninotto M; Secchiero S; Paleari CD; Burlina A
    Ther Drug Monit; 1992 Aug; 14(4):301-5. PubMed ID: 1519304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fluorescence polarization immunoassay and high performance liquid chromatography for the quantitative determination of phenytoin, phenobarbitone and carbamazepine in serum.
    Ashy AR; el-Sayed YM; Islam SI
    J Pharm Pharmacol; 1986 Aug; 38(8):572-7. PubMed ID: 2876072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a new automated substrate-labeled fluorescence immunoassay system evaluated by comparative therapeutic monitoring of five drugs.
    Klotz U
    Ther Drug Monit; 1984; 6(3):355-9. PubMed ID: 6390798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated homogeneous liposome immunoassay systems for anticonvulsant drugs.
    Kubotsu K; Goto S; Fujita M; Tuchiya H; Kida M; Takano S; Matsuura S; Sakurabayashi I
    Clin Chem; 1992 Jun; 38(6):808-12. PubMed ID: 1597006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence polarization immunoassay IV. Determination of phenytoin and phenobarbital in human serum and plasma.
    Lu-Steffes M; Pittluck GW; Jolley ME; Panas HN; Olive DL; Wang CH; Nystrom DD; Keegan CL; Davis TP; Stroupe SD
    Clin Chem; 1982 Nov; 28(11):2278-82. PubMed ID: 6751601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of enzyme immunoassay and fluorescence polarization immunoassay as techniques for measuring anticonvulsant drugs on the same analytical instrument.
    Thomas KC; Hullin DA; Davis SJ
    Ther Drug Monit; 1991 Mar; 13(2):172-6. PubMed ID: 2053126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methods of monitoring therapeutic agents. I. Use of homogeneous fluorescence immunoanalysis with substrate markers].
    Babjuk J; Bilyk I; Kalousová J; Nekvasilová H; Rybáková B
    Cesk Farm; 1987 Sep; 36(7):322-6. PubMed ID: 3311389
    [No Abstract]   [Full Text] [Related]  

  • 15. A new dry chemistry immunoassay: comparison with a fluorescence polarization system.
    Capone D; De Marino V; Pisanti N; De Marino V
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):91-4. PubMed ID: 7480966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation of EMIT drug assays to a random-access automated clinical analyzer.
    Boyd JC; Savory MG; Margrey M; Herold DA; Shipe JR; Savory J
    Ann Clin Lab Sci; 1985; 15(1):39-44. PubMed ID: 3882047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
    Sedman AJ; Molitoris BA; Nakata LM; Gal J
    Am J Nephrol; 1986; 6(2):132-4. PubMed ID: 3085501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated fluorometer/photometer system for homogeneous immunoassays.
    Li TM; Robertson SP; Crouch TH; Pahuski EE; Bush GA; Hydo SJ
    Clin Chem; 1983 Sep; 29(9):1628-34. PubMed ID: 6349854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical validation of a quantitative method for therapeutic drug monitoring on the Alinity
    Dubois N; Sqalli G; Gilson M; Charlier C
    Ann Biol Clin (Paris); 2020 Apr; 78(2):147-155. PubMed ID: 32319943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence polarization immunoassay of gentamicin or netilmicin in blood spotted on filter paper.
    Fujimoto T; Tsuda Y; Tawa R; Hirose S
    Clin Chem; 1989 May; 35(5):867-9. PubMed ID: 2720984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.